BE-80-2100577 part 1

Trial medication for inflammatory bowel diseases

18 - 55
  • Male
  • Female
March - April
< 7 days
10
2550

Are you:

  • a healthy male or female
  • aged from 18 en 55 years (inclusive)
  • with a BMI 18,5 to 27,0 kg/m² 
  • a non-smoker or stopped smoking min. 6 months before the first dose of study medication) 
  • not using daily medication

What does this trial involve?

SGS trial BE-80-2100577 part 1 investigates the treatment of inflammatory bowel diseases. You will have the following appointments over 12 weeks:

  • screening
  • 5-day (4-night) stay
  • 10 short follow-up visits
  • a final examination

Take part in this trial and

  • help us develop tomorrow's medicines
  • and receive a generous tax-free (in Belgium) payment of € 2550

View information leaflet

 

BE-80-2100577 part 1

Registration form

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Any other questions?

Ask your question